Myasthenic Syndromes, Congenital
4 clinical trials · Condition
◉ Watch Myasthenic Syndromes, Congenital
| Record | Firm | Date |
|---|---|---|
| Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes (NCT02562066) | Catalyst Pharmaceuticals, Inc. | 2016-01-01 |
| Ephedrine for the Treatment of Congenital Myasthenia (NCT00541216) | Hadassah Medical Organization | 2007-10-01 |
| Treatment Use of 3,4-Diaminopyridine (NCT01765140) | Vern C. Juel, M.D. |
Track Myasthenic Syndromes, Congenital automatically
Every clearance here is in the API, with alerts when new ones post.